EVMN Evommune, Inc. Common Stock
$14,71
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$10–$33
19% of range
Analystenbewertung
BUY
17 analysts
Kursziel
$28
+87% upside
P/E (TTM)
-1.3
ROE
-401.2%
Nettogewinnmarge
-529.8%
EVMN Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$14.71
Marktkapitalisierung
$464M
P/E (TTM)
-1.3
EPS (TTM)
$-11.22
Umsatz (TTM)
$13M
Dividendenrendite
—
ROE
-401.2%
Verschuldungsgrad
—
52W-Spanne
$10 – $33
EVMN Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$13M
2024-12-31
→
2025-12-31
EPS
$-11.22
2024-12-31
→
2025-12-31
Freier Cashflow
$-77M
2025-12-31
→
2025-12-31
Margen
-529.8%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
EVMN
Peer-Median
P/E (TTM)
-1.3
—
P/S (TTM) (K/V (TTM))
35.7
61.3
P/B (K/B)
2.3
2.0
Price / FCF (Kurs / FCF)
-6.0
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
EVMN
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-623.6%
—
Net Profit Margin (Nettogewinnmarge)
-529.8%
-498.7%
ROA
-45.8%
-52.4%
ROE
-401.2%
-60.2%
ROIC
-39.4%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
EVMN
Peer-Median
Current Ratio (Liquiditätsgrad)
8.6
8.8
Quick Ratio
8.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
EVMN
Peer-Median
Revenue YoY (Umsatz YoY)
85.7%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
EVMN
Peer-Median
EVMN Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
17 Analysten
- Starker Kauf 5 29,4%
- Kauf 9 52,9%
- Halten 3 17,6%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
7 Analysten · 2026-08-13
Median
$28.00
← Unter allen Zielen
$14.71
Tief
$22.00
Hoch
$32.00
Median-Ziel
$28.00
+90,3%
Mittelwert-Ziel
$27.57
+87,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.21%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.89 | $-0.68 | -0.21% |
| 31. März 2026 | $-0.64 | $-0.76 | 0.12% |
| 31. Dezember 2025 | $-1.43 | $-0.90 | -0.53% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | — |
| ZURA | — | — | — | — | — | — |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| QTTB | $43M | 1.4 | — | 55.5% | 200.3% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $13M | $7M | |
| R&D Expense | $74M | $64M | |
| SG&A Expense | $20M | $13M | |
| Operating Expenses | $94M | $77M | |
| Operating Income | $-81M | $-70M | |
| Interest Income | $3M | $3M | |
| Other Non-op | $12M | $3M | |
| Pretax Income | $-69M | $-68M | |
| Income Tax | $0 | $0 | |
| Net Income | $-69M | $-67M | |
| EPS (Basic) | $-11.22 | $-45.29 | |
| EPS (Diluted) | $-11.22 | $-45.29 | |
| Shares (Basic) | 6,136,636 | 1,508,284 | |
| Shares (Diluted) | 6,136,636 | 1,508,284 | |
| EBITDA | $-80M | · |
Bilanz 20
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $44M | $16M | |
| Short-term Investments | $105M | $56M | |
| Prepaid Expense | $4M | $2M | |
| Current Assets | $153M | $74M | |
| PP&E (Net) | $994.0K | $1M | |
| PP&E (Gross) | $3M | $2M | |
| Accum. Depreciation | $2M | $948.0K | |
| Other Non-current Assets | $101.0K | $61.0K | |
| Total Assets | $225M | $76M | |
| Accounts Payable | $8M | $8M | |
| Accrued Liabilities | $10M | $7M | |
| Current Liabilities | $18M | $28M | |
| Capital Leases | $1M | · | |
| Other Non-current Liabilities | · | $535.0K | |
| Total Liabilities | $19M | $29M | |
| Common Stock | $3.0K | $0 | |
| Retained Earnings | $-221M | $-152M | |
| Stockholders' Equity | $206M | $-144M | |
| Liabilities + Equity | $225M | $76M | |
| Shares Outstanding | 31,524,093 | 1,551,420 |
Cashflow 9
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $600.0K | $500.0K | |
| Stock-based Comp | $6M | $2M | |
| Other Non-cash | $-14M | · | |
| Operating Cash Flow | $-76M | $-58M | |
| CapEx | $235.0K | $88.0K | |
| Investing Cash Flow | $-115M | $-4M | |
| Financing Cash Flow | $221M | $49M | |
| Net Change in Cash | $29M | $-13M | |
| Free Cash Flow | $-77M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -623.6% | · | |
| Net Margin | -529.8% | · | |
| Pretax Margin | -529.8% | · | |
| EBITDA Margin | -619.0% | · | |
| ROA | -45.8% | · | |
| ROE | -401.2% | · | |
| ROIC | -39.4% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 8.6 | · | |
| Quick Ratio | 8.3 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.1 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 85.7% | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $13M | · | |
| Net Income TTM | $-69M | · | |
| Market Cap | $540M | · | |
| P/E | -1.5 | · | |
| P/S | 41.5 | · | |
| P/B | 2.6 | · | |
| P / Tangible Book | 2.6 | · | |
| P / Cash Flow | -7.1 | · | |
| P / FCF | -7.0 | · | |
| Earnings Yield | -65.5% | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $10M | $0 | $3M | $0 | |
| R&D Expense | $26M | $17M | $20M | $20M | $20M | $14M | $18M | |
| SG&A Expense | $8M | $7M | $9M | $4M | $3M | $4M | $4M | |
| Operating Expenses | $35M | $24M | $30M | $23M | $23M | $18M | $21M | |
| Operating Income | $-35M | $-24M | $-30M | $-13M | $-23M | $-15M | $-21M | |
| Interest Income | $3M | $2M | $1M | $862.0K | $403.0K | $613.0K | $727.0K | |
| Other Non-op | $3M | $2M | $1M | $853.0K | $9M | $475.0K | $728.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-32M | $-22M | $-28M | $-12M | $-14M | $-15M | $-21M | |
| EPS (Basic) | $-0.89 | $-0.64 | $15.14 | $-8.07 | $-8.80 | $-9.48 | $-14.60 | |
| EPS (Diluted) | $-0.89 | $-0.64 | $15.14 | $-8.07 | $-8.80 | $-9.48 | $-14.60 | |
| Shares (Basic) | 36,135,644 | 33,670,148 | 4,596,393 | 1,545,010 | 1,540,695 | 1,534,965 | 6,649 | |
| Shares (Diluted) | 36,135,644 | 33,670,148 | 4,596,393 | 1,545,010 | 1,540,695 | 1,534,965 | 6,649 | |
| EBITDA | $-35M | $-24M | · | $-13M | · | · | · |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $48M | $44M | $27M | · | · | $16M | |
| Short-term Investments | $141M | $163M | $105M | $49M | · | · | $56M | |
| Prepaid Expense | $3M | $4M | $4M | $6M | · | · | $2M | |
| Current Assets | $204M | $216M | $153M | $82M | · | · | $74M | |
| PP&E (Net) | $2M | $2M | $994.0K | $970.0K | · | · | $1M | |
| PP&E (Gross) | $3M | $3M | $3M | · | · | · | $2M | |
| Accum. Depreciation | $2M | $1M | $2M | · | · | · | $948.0K | |
| Other Non-current Assets | $66.0K | $73.0K | $101.0K | $61.0K | · | · | $61.0K | |
| Total Assets | $302M | $322M | $225M | $85M | · | · | $76M | |
| Accounts Payable | $5M | $4M | $8M | $4M | · | · | $8M | |
| Accrued Liabilities | $11M | $5M | $10M | $6M | · | · | $7M | |
| Current Liabilities | $17M | $11M | $18M | $10M | · | · | $28M | |
| Capital Leases | $6M | $7M | $1M | $0 | · | · | · | |
| Other Non-current Liabilities | · | · | · | $261.0K | · | · | · | |
| Total Liabilities | $24M | $18M | $19M | $11M | · | · | $29M | |
| Common Stock | $4.0K | $4.0K | $3.0K | $0 | · | · | $0 | |
| Retained Earnings | $-275M | $-243M | $-221M | $-193M | · | · | $-152M | |
| Stockholders' Equity | $278M | $305M | $206M | $-183M | · | · | $-144M | |
| Liabilities + Equity | $302M | $322M | $225M | $85M | · | · | $76M | |
| Shares Outstanding | 36,281,767 | 36,018,372 | 31,524,093 | 1,554,965 | · | · | 1,551,420 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| D&A | $200.0K | $100.0K | $326.0K | $311.0K | $200.0K | $200.0K | $360.0K | |
| Stock-based Comp | $5M | $3M | $4M | $560.0K | $556.0K | $544.0K | $494.0K | |
| Other Non-cash | · | $-9M | · | · | · | · | · | |
| Operating Cash Flow | $-20M | $-28M | $-17M | $-10M | $-26M | $-24M | $-19M | |
| CapEx | $183.0K | $83.0K | $104.0K | $131.0K | $0 | $0 | $0 | |
| Investing Cash Flow | $31M | $-85M | $-123M | $-24M | $18M | $14M | $-33M | |
| Financing Cash Flow | $532.0K | $117M | $157M | $-274.0K | $64M | $-152.0K | $50M | |
| Net Change in Cash | $12M | $4M | $17M | $-34M | $56M | $-11M | $-2M | |
| Free Cash Flow | · | $-28M | · | · | · | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -133.3% | · | · | · | |
| Net Margin | · | · | · | -124.8% | · | · | · | |
| EBITDA Margin | · | · | · | -133.3% | · | · | · | |
| ROA | -21.4% | -13.4% | · | -29.5% | · | · | · | |
| ROE | -23.2% | -14.2% | · | 13.6% | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.7 | 20.4 | · | 7.9 | · | · | · | |
| Quick Ratio | 11.5 | 19.9 | · | 7.3 | · | · | · |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.2 | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | · | · | · | · | · | · | |
| Net Income TTM | $-80M | · | · | · | · | · | · | |
| Market Cap | $482M | $828M | · | · | · | · | · | |
| P/E | -0.7 | · | · | · | · | · | · | |
| P/S | 48.2 | · | · | · | · | · | · | |
| P/B | 1.7 | 2.7 | · | · | · | · | · | |
| P / Tangible Book | 1.7 | 2.7 | · | · | · | · | · | |
| P / Cash Flow | · | -30.1 | · | · | · | · | · | |
| P / FCF | · | -30.0 | · | · | · | · | · | |
| Earnings Yield | -138.5% | · | · | · | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Umsatz | $13M | $7M |
| Betriebsgewinnmarge % | -623.6% | — |
| Nettoergebnis | $-69M | $-67M |
| Verwässerte EPS | $-11.22 | $-45.29 |
Bilanz
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Liquiditätsgrad | 8.6 | — |
| Quick Ratio | 8.3 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Freier Cashflow | $-77M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 119 Einreicher · $451.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 56 (+24 vs. Vorquartal) | 17 (+7 vs. Vorquartal) | 25 (+3 vs. Vorquartal) | 17 (+3 vs. Vorquartal) | +1.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| EQT Fund Management S.a r.l. | $70.281.680 | 5.288.313 | 15,57% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $46.443.739 | 3.494.638 | 10,29% | Aktien |
| SymBiosis Capital Partners, LLC | $29.445.086 | 1.280.778 | 6,52% | Aktien |
| Pivotal bioVenture Partners Investment Advisor LLC | $25.609.072 | 1.926.943 | 5,67% | Aktien |
| JANUS HENDERSON GROUP PLC | $20.615.133 | 896.700 | 4,57% | Aktien |
| RTW INVESTMENTS, LP | $19.964.703 | 1.502.235 | 4,42% | Aktien |
| Nan Fung Group Holdings Ltd | $19.151.315 | 1.441.032 | 4,24% | Aktien |
| Point72 Asset Management, L.P. | $19.071.801 | 1.435.049 | 4,22% | Aktien |
| ANDERA PARTNERS | $18.499.547 | 1.391.990 | 4,10% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $16.069.325 | 1.209.129 | 3,56% | Aktien |
| Vestal Point Capital, LP | $13.290.000 | 1.000.000 | 2,94% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $11.720.385 | 881.895 | 2,60% | Aktien |
| BAKER BROS. ADVISORS LP | $11.261.813 | 847.390 | 2,49% | Aktien |
| Defilade Capital Management, L.P. | $10.540.897 | 793.145 | 2,33% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $10.034.211 | 755.018 | 2,22% | Aktien |
| Alyeska Investment Group, L.P. | $9.361.808 | 704.425 | 2,07% | Aktien |
| VANGUARD GROUP INC | $7.588.029 | 443.226 | 1,68% | Aktien |
| Affinity Asset Advisors, LLC | $6.646.329 | 500.100 | 1,47% | Verkaufsoption |
| Balyasny Asset Management L.P. | $6.073.729 | 457.015 | 1,35% | Aktien |
| Velan Capital Investment Management LP | $5.930.729 | 446.255 | 1,31% | Aktien |
| UBS Group AG | $5.481.939 | 412.486 | 1,21% | Aktien |
| FEDERATED HERMES, INC. | $4.319.250 | 325.000 | 0,96% | Aktien |
| GREAT POINT PARTNERS LLC | $4.319.250 | 325.000 | 0,96% | Aktien |
| Freestone Grove Partners LP | $4.071.099 | 306.328 | 0,90% | Aktien |
| STATE STREET CORP | $3.900.828 | 293.516 | 0,86% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $3.428.090 | 257.874 | 0,76% | Aktien |
| Blue Owl Capital Holdings LP | $2.392.200 | 180.000 | 0,53% | Aktien |
| Eversept Partners, LP | $2.318.573 | 174.460 | 0,51% | Aktien |
| Balyasny Asset Management L.P. | $2.259.300 | 170.000 | 0,50% | Kaufoption |
| JANE STREET GROUP, LLC | $2.238.249 | 168.416 | 0,50% | Aktien |
| Caption Management, LLC | $2.204.811 | 165.900 | 0,49% | Kaufoption |
| ORBIMED ADVISORS LLC | $2.139.690 | 161.000 | 0,47% | Aktien |
| GOLDMAN SACHS GROUP INC | $2.137.258 | 160.817 | 0,47% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.772.222 | 133.350 | 0,39% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.768.527 | 133.072 | 0,39% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.593.830 | 119.927 | 0,35% | Aktien |
| NEXTBio Capital Management LP | $1.582.347 | 119.063 | 0,35% | Aktien |
| LMR Partners LLP | $1.574.014 | 118.436 | 0,35% | Aktien |
| Longaeva Partners L.P. | $1.549.760 | 116.611 | 0,34% | Aktien |
| Holocene Advisors, LP | $1.476.944 | 111.132 | 0,33% | Aktien |
| ADAR1 Capital Management, LLC | $1.382.625 | 104.035 | 0,31% | Aktien |
| SEVEN GRAND MANAGERS, LLC | $1.203.649 | 90.568 | 0,27% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.172.165 | 88.199 | 0,26% | Aktien |
| AMERIPRISE FINANCIAL INC | $1.156.469 | 87.018 | 0,26% | Aktien |
| Avidity Partners Management LP | $996.750 | 75.000 | 0,22% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $956.880 | 72.000 | 0,21% | Kaufoption |
| Quadrature Capital Ltd | $921.143 | 69.311 | 0,20% | Aktien |
| XTX Topco Ltd | $806.623 | 60.694 | 0,18% | Aktien |
| TD Asset Management Inc | $806.198 | 60.662 | 0,18% | Aktien |
| CANTOR FITZGERALD, L. P. | $688.369 | 51.796 | 0,15% | Aktien |
| Burkehill Global Management, LP | $664.500 | 50.000 | 0,15% | Aktien |
| Caption Management, LLC | $637.920 | 48.000 | 0,14% | Verkaufsoption |
| Squarepoint Ops LLC | $633.960 | 47.702 | 0,14% | Aktien |
| Verition Fund Management LLC | $583.909 | 43.936 | 0,13% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $538.245 | 40.500 | 0,12% | Verkaufsoption |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $517.087 | 38.908 | 0,11% | Aktien |
| CITADEL ADVISORS LLC | $494.388 | 37.200 | 0,11% | Verkaufsoption |
| ALPS ADVISORS INC | $485.856 | 36.558 | 0,11% | Aktien |
| Caption Management, LLC | $406.421 | 30.581 | 0,09% | Aktien |
| Jump Financial, LLC | $401.358 | 30.200 | 0,09% | Aktien |
| Qube Research & Technologies Ltd | $400.228 | 30.115 | 0,09% | Aktien |
| JANE STREET GROUP, LLC | $388.068 | 29.200 | 0,09% | Kaufoption |
| Y-Intercept (Hong Kong) Ltd | $377.409 | 28.398 | 0,08% | Aktien |
| JPMORGAN CHASE & CO | $367.250 | 24.402 | 0,08% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $362.322 | 15.760 | 0,08% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $339.241 | 25.526 | 0,08% | Aktien |
| J. Safra Sarasin Holding AG | $321.844 | 24.217 | 0,07% | Aktien |
| Cinctive Capital Management LP | $313.086 | 23.558 | 0,07% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $300.779 | 22.632 | 0,07% | Aktien |
| Swiss National Bank | $288.393 | 21.700 | 0,06% | Aktien |
| Virtus Investment Advisers, LLC | $219.285 | 16.500 | 0,05% | Aktien |
| ExodusPoint Capital Management, LP | $202.367 | 15.227 | 0,04% | Aktien |
| RHUMBLINE ADVISERS | $192.628 | 14.495 | 0,04% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $175.215 | 13.184 | 0,04% | Aktien |
| BANK OF AMERICA CORP /DE/ | $144.436 | 10.868 | 0,03% | Aktien |
| CITADEL ADVISORS LLC | $142.522 | 10.724 | 0,03% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $106.400 | 8.006 | 0,02% | Aktien |
| BlackRock, Inc. | $104.087 | 7.832 | 0,02% | Aktien |
| Quantbot Technologies LP | $101.536 | 7.640 | 0,02% | Aktien |
| MetLife Investment Management, LLC | $93.336 | 7.023 | 0,02% | Aktien |
| Bank of New York Mellon Corp | $91.076 | 6.853 | 0,02% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $88.844 | 6.685 | 0,02% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $77.587 | 5.838 | 0,02% | Aktien |
| CITIGROUP INC | $73.361 | 5.520 | 0,02% | Aktien |
| NATIXIS | $69.355 | 5.044 | 0,02% | Aktien |
| TORONTO DOMINION BANK | $65.121 | 4.900 | 0,01% | Kaufoption |
| NEW YORK STATE COMMON RETIREMENT FUND | $57.147 | 4.300 | 0,01% | Aktien |
| Nuveen, LLC | $53.665 | 4.038 | 0,01% | Aktien |
| Vanguard Global Advisers, LLC | $49.970 | 3.760 | 0,01% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $39.950 | 3.006 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $38.169 | 2.872 | 0,01% | Aktien |
| KLP KAPITALFORVALTNING AS | $31.896 | 2.400 | 0,01% | Aktien |
| NORTHERN TRUST CORP | $26.460 | 1.991 | 0,01% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $25.494 | 1.918.277 | 0,01% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $23.922 | 1.800 | 0,01% | Aktien |
| BARCLAYS PLC | $21.690 | 1.632 | 0,00% | Aktien |
| Legal & General Group Plc | $16.360 | 1.231 | 0,00% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $13.127 | 571 | 0,00% | Aktien |
| Ameritas Investment Partners, Inc. | $11.363 | 855 | 0,00% | Aktien |
| State of Wyoming | $11.137 | 838 | 0,00% | Aktien |
Unternehmensinsider 11 Insider · 5 Führungskräfte · 6 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Luis C. Pena | President & CEO | 22. Juni 2026 S | 630.458 | 0 | 2 | $-550.653 |
| Kyle Carver | Chief Financial Officer | 28. Mai 2026 M | 59.335 | 0 | 1 | $-415.117 |
| Jeegar Pravinkumar Patel | Chief Scientific Officer | 22. Juni 2026 M | 46.403 | 0 | 2 | $-412.942 |
| Janice Suzann Drew | Chief of Dev. Operations | 22. Juni 2026 M | 67.794 | 0 | 1 | $-452.600 |
| Gregory S. Moss | Chief Business & Legal Officer | 28. Mai 2026 M | 60.835 | 0 | 1 | $-324.711 |
| Arthur S Kirsch | Direktor | 7. Juli 2026 P | 10.000 | 1 | 0 | $133.000 |
| David E Cohen | Direktor | 2. Juni 2026 A | 17.609 | 0 | 2 | $-123.094 |
| Benjamin F Mcgraw III | Direktor | 2. Juni 2026 A | — | 0 | 0 | $0 |
| LSP 7 Cooperatieve U.A. | Direktor | 17. Februar 2026 A | 5.288.313 | 0 | 0 | $0 |
| Robert Lorne Hopfner | Direktor | 19. Dezember 2025 P | 4.026 | 1 | 0 | $17.350 |
| RA Capital Management, L.P. | — | 7. November 2025 C | 784.345 | 2 | 0 | $20.000.000 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| LSP 7 Cooperatieve U.A., LSP 7 Management B.V. ×2 Einreichungen | 19. Februar 2026 | 14,70% | Änderung | — | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×2 Einreichungen | 17. Februar 2026 | 9,70% | Änderung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 19 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,27% | 1.260 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,04% | 42.650 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 116.175 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 72.976 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 13.523 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,01% | 5.847 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 4.557 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 492 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 325.390 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 53.264 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,00% | 831 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,00% | 384 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 388 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 10 NS | 31. Mai 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 6.000 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 126.549 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 739.068 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 888 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 32.540 SH | 8. August 2026 | Täglich |